Voriconazole: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>David E. Volk
imported>David E. Volk
Line 20: Line 20:


== Mechanism of action ==
== Mechanism of action ==
Azole-based antifungal agents, such as voriconazole, inhibit the enzyme cytochrome P450 enzyme [[14-alpha-methylase]], and by doing so stop the conversion of [[lanosterol]] to [[ergosterol]], an important component of fungal cell wall membranes.  The lack of ergosterol makes the fungal cell wall permeable and inhibits cell growth.
Azole-based antifungal agents, such as voriconazole, inhibit the cytochrome P450 enzyme [[14-alpha-demethylase]], and by doing so stop the conversion of [[lanosterol]] to [[ergosterol]], an important component of fungal cell wall membranes.  The lack of ergosterol makes the fungal cell wall permeable and inhibits cell growth.


== Chemistry ==
== Chemistry ==

Revision as of 15:47, 16 May 2008

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.
Voriconazole.jpg
voriconazole
IUPAC name: see chemistry section
Synonyms: VCZ
Formula: C16H14F3N5O

 Uses: antifungal drug

 Properties: azole compound

 Hazards: see side effects & drug interactions

Mass (g/mol): CAS #:
349.3105 137234-62-9


Voriconazole is a triazole-based antifungal drug used to treat infections due to fungi, generally used to treat invasive infection in immunocompromised patients. It is used to treat candidiasis, apergillosis, Scedosporium apiospermum and Fusarium species including Fusarium solani.


Mechanism of action

Azole-based antifungal agents, such as voriconazole, inhibit the cytochrome P450 enzyme 14-alpha-demethylase, and by doing so stop the conversion of lanosterol to ergosterol, an important component of fungal cell wall membranes. The lack of ergosterol makes the fungal cell wall permeable and inhibits cell growth.

Chemistry

The IUPAC name of voriconazole is (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan- 2-ol and its molecular formula, C16H14F3N5O, gives it a molecular mass of 349.3105 g/mol. The activity of the drug is based on the presence of an azole.

References & external links